As noted earlier, tumor cells exploit ICP pathways, such as PD-1, PD-L1, CTLA-4, and FOXP3-expressing Tregs, to dampen T-cell activity and escape immune surveillance [141]. The gene discussed is CD274; the disease is neoplasm.